Skip to main navigation Skip to search Skip to main content

Anticholinergic burden and revisit risk in frail patients with pharmacological sleepiness

Jesus Ruiz Ramos, L. López-Vinardell, L. Higa-Sansone, B. Torrecilla-Vall-Llossera, M. Puig-Campmany, M.A. Mangues-Bafalluy, A. Juanes-Borrego

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Objective: Drug-induced sleepiness is a frequent cause of emergency department (ED) visits for frail patients. The aim of this study was to assess the impact of anticholinergic burden on 90-day revisitation risk for frail patients who visit the ED due to drug-induced sleepiness. Methods: This was a retrospective study in which patients treated at a fragility care area of an ED who sought consultation for drug-associated sleepiness from June 2020 to June 2021 were included. To evaluate the 90-day revisitation risk factors, a multivariate analysis was performed, including those factors with a p
Original languageEnglish
Article numberA881
JournalEuropean Journal of Hospital Pharmacy
DOIs
Publication statusPublished - 2022

Keywords

  • DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS
  • EMERGENCY MEDICINE
  • GERIATRICS
  • PRIMARY HEALTH CARE
  • SAFETY

Fingerprint

Dive into the research topics of 'Anticholinergic burden and revisit risk in frail patients with pharmacological sleepiness'. Together they form a unique fingerprint.

Cite this